These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28605429)

  • 21. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
    Lane CR; Carville KS; Pierse N; Kelly HA
    Vaccine; 2016 Feb; 34(8):1070-6. PubMed ID: 26795366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
    Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ
    Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza Transmission Dynamics in Urban Households, Managua, Nicaragua, 2012-2014.
    Gordon A; Tsang TK; Cowling BJ; Kuan G; Ojeda S; Sanchez N; Gresh L; Lopez R; Balmaseda A; Harris E
    Emerg Infect Dis; 2018 Oct; 24(10):1882-1888. PubMed ID: 30226161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009.
    Jackson ML; France AM; Hancock K; Lu X; Veguilla V; Sun H; Liu F; Hadler J; Harcourt BH; Esposito DH; Zimmerman CM; Katz JM; Fry AM; Schrag SJ
    Clin Infect Dis; 2011 Sep; 53(5):455-62. PubMed ID: 21844028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017.
    Hergens MP; Baum U; Brytting M; Ikonen N; Haveri A; Wiman Å; Nohynek H; Örtqvist Å
    Euro Surveill; 2017 Feb; 22(8):. PubMed ID: 28251891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method.
    Vilcu AM; Souty C; Enouf V; Capai L; Turbelin C; Masse S; Behillil S; Valette M; Guerrisi C; Rossignol L; Blanchon T; Lina B; Hanslik T; Falchi A
    Clin Microbiol Infect; 2018 Apr; 24(4):431.e5-431.e12. PubMed ID: 28899840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
    Pisu M; Meltzer MI; Hurwitz ES; Haber M
    Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data.
    Cauchemez S; Carrat F; Viboud C; Valleron AJ; Boëlle PY
    Stat Med; 2004 Nov; 23(22):3469-87. PubMed ID: 15505892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study.
    Helmeke C; Gräfe L; Irmscher HM; Gottschalk C; Karagiannis I; Oppermann H
    PLoS One; 2015; 10(4):e0122910. PubMed ID: 25885063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Zhang L; Pan Y; Hackert V; van der Hoek W; Meijer A; Krafft T; Yang P; Wang Q
    Vaccine; 2018 Aug; 36(33):4993-5001. PubMed ID: 30017144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of influenza transmission in South East Asia: insights from a household cohort study in Vietnam.
    Cauchemez S; Ferguson NM; Fox A; Mai le Q; Thanh le T; Thai PQ; Thoang DD; Duong TN; Minh Hoa le N; Tran Hien N; Horby P
    PLoS Pathog; 2014 Aug; 10(8):e1004310. PubMed ID: 25144780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Tam YH; Ng TWY; Chu DKW; Fang VJ; Cowling BJ; Malik Peiris JS; Ip DKM
    Vaccine; 2018 Oct; 36(41):6117-6123. PubMed ID: 30190121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.